Incidence of hypothyroidism in girls with Turner syndrome in Korea on the basis of real-world evidence from the Korean National Health Insurance Service database.

IF 5.2 1区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Hong Kyu Park, Young Suk Shim, Hae Sang Lee
{"title":"Incidence of hypothyroidism in girls with Turner syndrome in Korea on the basis of real-world evidence from the Korean National Health Insurance Service database.","authors":"Hong Kyu Park, Young Suk Shim, Hae Sang Lee","doi":"10.1093/ejendo/lvaf150","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Hypothyroidism is the most commonly observed autoimmune disorder in individuals with Turner syndrome. The aim of this study was to determine the risk of hypothyroidism in patients with Turner syndrome by comparing its incidence in this patient population to that in the general population.</p><p><strong>Design: </strong>In this retrospective cohort study, patients in South Korea were followed for 10 years, and claims data from the National Health Insurance Service database were collected between 2007 and 2019.</p><p><strong>Methods: </strong>The incidence of hypothyroidism among patients with Turner syndrome and in the general population under 65 years of age was determined. Turner syndrome was identified by at least 2 diagnosis codes, and hypothyroidism was defined by the prescription of thyroid hormone analogs lasting 180 days or more, accompanied by a hypothyroidism diagnosis code. Subscribers who had records related to medical conditions that required thyroid hormone replacement were excluded from the cohort.</p><p><strong>Results: </strong>The cohort included 2973 patients with Turner syndrome and 21 239 127 females. Hypothyroidism developed in 11.4% of the patients with Turner syndrome and in 2.9% of the general population. The incidence rates per 10 000 person-years among patients with Turner syndrome were 86.9 (95% CI, 64.5-114.6), 101.0 (95% CI, 82.2-122.9), 139.6 (95% CI, 113.3-170.1), and 139.4 (95% CI, 112.1-171.3) in the groups aged 0-9, 10-19, 20-29, and 30-65 years, respectively, and those in the general population were 1.7 (95% CI, 1.6-1.7), 5.0 (95% CI, 5.0-5.1), 29.7 (95% CI, 29.5-29.9), and 39.1 (95% CI, 39.0-39.2), respectively. The risk of hypothyroidism in patients with Turner syndrome was approximately 45 times greater than that in the general population before 10 years of age.</p><p><strong>Conclusions: </strong>Regular thyroid function testing and antibody screening should be initiated early in life to facilitate the early detection of hypothyroidism in patients with Turner syndrome.</p>","PeriodicalId":11884,"journal":{"name":"European Journal of Endocrinology","volume":"193 2","pages":"232-239"},"PeriodicalIF":5.2000,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Endocrinology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ejendo/lvaf150","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Hypothyroidism is the most commonly observed autoimmune disorder in individuals with Turner syndrome. The aim of this study was to determine the risk of hypothyroidism in patients with Turner syndrome by comparing its incidence in this patient population to that in the general population.

Design: In this retrospective cohort study, patients in South Korea were followed for 10 years, and claims data from the National Health Insurance Service database were collected between 2007 and 2019.

Methods: The incidence of hypothyroidism among patients with Turner syndrome and in the general population under 65 years of age was determined. Turner syndrome was identified by at least 2 diagnosis codes, and hypothyroidism was defined by the prescription of thyroid hormone analogs lasting 180 days or more, accompanied by a hypothyroidism diagnosis code. Subscribers who had records related to medical conditions that required thyroid hormone replacement were excluded from the cohort.

Results: The cohort included 2973 patients with Turner syndrome and 21 239 127 females. Hypothyroidism developed in 11.4% of the patients with Turner syndrome and in 2.9% of the general population. The incidence rates per 10 000 person-years among patients with Turner syndrome were 86.9 (95% CI, 64.5-114.6), 101.0 (95% CI, 82.2-122.9), 139.6 (95% CI, 113.3-170.1), and 139.4 (95% CI, 112.1-171.3) in the groups aged 0-9, 10-19, 20-29, and 30-65 years, respectively, and those in the general population were 1.7 (95% CI, 1.6-1.7), 5.0 (95% CI, 5.0-5.1), 29.7 (95% CI, 29.5-29.9), and 39.1 (95% CI, 39.0-39.2), respectively. The risk of hypothyroidism in patients with Turner syndrome was approximately 45 times greater than that in the general population before 10 years of age.

Conclusions: Regular thyroid function testing and antibody screening should be initiated early in life to facilitate the early detection of hypothyroidism in patients with Turner syndrome.

根据韩国国民健康保险服务数据库的真实世界证据,韩国特纳综合征女孩甲状腺功能减退的发病率。
目的:甲状腺功能减退是Turner综合征患者中最常见的自身免疫性疾病。本研究的目的是通过比较特纳综合征患者与普通人群的发病率,确定特纳综合征患者甲状腺功能减退的风险。设计:在这项回顾性队列研究中,对韩国患者进行了10年的随访,并收集了2007年至2019年期间国民健康保险服务数据库中的索赔数据。方法:测定特纳综合征患者和65岁以下普通人群甲状腺功能减退的发生率。Turner综合征至少有2个诊断代码,甲状腺功能减退症的定义是服用甲状腺激素类似物持续180天或更长时间,并伴有甲状腺功能减退诊断代码。有需要甲状腺激素替代的医疗记录的用户被排除在队列之外。结果:纳入特纳综合征患者2973例,女性21 239 127例。特纳综合征患者中有11.4%发生甲状腺功能减退,而一般人群中有2.9%发生甲状腺功能减退。在0-9岁、10-19岁、20-29岁和30-65岁年龄组中,特纳综合征患者每10000人年的发病率分别为86.9 (95% CI, 64.5-114.6)、101.0 (95% CI, 82.2-122.9)、139.6 (95% CI, 113.3-170.1)和139.4 (95% CI, 112.1-171.3),而在普通人群中,特纳综合征的发病率分别为1.7 (95% CI, 1.6-1.7)、5.0 (95% CI, 5.0-5.1)、29.7 (95% CI, 29.5-29.9)和39.1 (95% CI, 39.0-39.2)。特纳综合征患者发生甲状腺功能减退的风险大约是10岁前普通人群的45倍。结论:Turner综合征患者应及早进行定期甲状腺功能检查和抗体筛查,以便早期发现甲状腺功能减退。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Journal of Endocrinology
European Journal of Endocrinology 医学-内分泌学与代谢
CiteScore
9.80
自引率
3.40%
发文量
354
审稿时长
1 months
期刊介绍: European Journal of Endocrinology is the official journal of the European Society of Endocrinology. Its predecessor journal is Acta Endocrinologica. The journal publishes high-quality original clinical and translational research papers and reviews in paediatric and adult endocrinology, as well as clinical practice guidelines, position statements and debates. Case reports will only be considered if they represent exceptional insights or advances in clinical endocrinology. Topics covered include, but are not limited to, Adrenal and Steroid, Bone and Mineral Metabolism, Hormones and Cancer, Pituitary and Hypothalamus, Thyroid and Reproduction. In the field of Diabetes, Obesity and Metabolism we welcome manuscripts addressing endocrine mechanisms of disease and its complications, management of obesity/diabetes in the context of other endocrine conditions, or aspects of complex disease management. Reports may encompass natural history studies, mechanistic studies, or clinical trials. Equal consideration is given to all manuscripts in English from any country.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信